Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 136Motor Activity 72Fatigue 10Neoplasms 9Obesity 8Lymphedema 8Colorectal Neoplasms 7Cardiotoxicity 7Weight Loss 6Prostatic Neoplasms 5Breast Cancer Lymphedema 5Ovarian Neoplasms 3Breast Cancer Female 3Triple Negative Breast Neoplasms 2Recurrence 2Overweight 2Lymphoma, Non-Hodgkin 2Lymphoma 2Lung Neoplasms 2Insulin Resistance 2Depression 2Breast Diseases 2Breast Cancer Survivors 2Body Weight Changes 2Atherosclerosis 2Arthralgia 2Ventricular Dysfunction, Left 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

Trastuzumab 5Carboplatin 5Docetaxel 4pertuzumab 3Paclitaxel 3Cyclophosphamide 3pembrolizumab 2Epirubicin 2Doxorubicin 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1taxane 1talazoparib 1sarilumab 1pyrotinib 1pirarubicin 1pexidartinib 1patritumab 1olaparib 1niraparib 1neratinib 1ganitumab 1durvalumab 1dostarlimab 1cemiplimab 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Exercise × Breast × Clear all
NCT07066189 2025-10-29

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Yale University

Phase NA Recruiting
160 enrolled
Breast

Pathologic Complete Response, Motor Activity, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡